Chao Tang
Direktor/Vorstandsmitglied bei GENETRON HOLDINGS LIMITED
Profil
Chao Tang is currently a Director at Genetron Holdings Ltd.
and an Executive Dean at Peking University.
Previously, he worked as a Professor at The University of California, San Francisco.
He holds a doctorate degree from The University of Chicago and an undergraduate degree from the University of Science & Technology of China.
Aktive Positionen von Chao Tang
| Unternehmen | Position | Beginn |
|---|---|---|
| GENETRON HOLDINGS LIMITED | Direktor/Vorstandsmitglied | 01.06.2021 |
Peking University
 Peking University Other Consumer ServicesConsumer Services Peking University provides post-secondary education services. It offers undergraduate and graduate courses. It provides courses such as basic and applied sciences, social sciences and the humanities, sciences of medicine, management, and education. The company was founded by JiaNai Sun in 1898 and is headquartered in Beijing, China. | Corporate Officer/Principal | - |
Ehemalige bekannte Positionen von Chao Tang
| Unternehmen | Position | Ende |
|---|---|---|
| The University of California, San Francisco | Corporate Officer/Principal | - |
Ausbildung von Chao Tang
| University of Science & Technology of China | Undergraduate Degree |
| The University of Chicago | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 1 |
|---|---|
Genetron Holdings Ltd.
 Genetron Holdings Ltd. Medical/Nursing ServicesHealth Services Genetron Holdings, Ltd. engages in precision oncology. It provides cancer molecular profiling by using technologies in molecular biology and data science to transform cancer treatment. It products and services include diagnosis and monitoring through both LDT and IVD products. Its LDT portfolio consists of both specifically designed focused and comprehensive gene panel testing services. It also develops liver cancer early screening products. The company was founded by Si Zhen Wang, Hai Yan, and Wei Wu He in 2015 and is headquartered in Beijing, China. | Health Services |
